Biomarin Pharmaceutical Inc. · NASDAQ:BMRN
Vanguard Capital Management LLC reported a 5.25% stake in Biomarin Pharmaceutical Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.25% stake in Biomarin Pharmaceutical Inc., 10,113,219 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.25%
- Shares
- 10,113,219
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.25% | 10,113,219 |
Source
Related
- Biomarin Pharmaceutical Inc.
- Vanguard Capital Management LLC
- Biomarin Pharmaceutical Inc. shareholders
- Form 4 · Friberg Gregory R · Oct 1, 2026
- Form 4 · Plenge Robert M · Sep 14, 2026
- Form 4 · Davis George Eric · Sep 3, 2026
- Form 4 · Countouriotis Athena · Jun 4, 2026
- Form 4 · Walbert Timothy P · Jun 4, 2026